Modulation of Drug Transporters at the Blood-Brain Barrier
- 4 March 2004
- journal article
- review article
- Published by S. Karger AG in Pharmacology
- Vol. 70 (4) , 169-176
- https://doi.org/10.1159/000075545
Abstract
A major challenge in the management of diseases of the central nervous system is the limited penetration of drugs into the brain. The structures responsible are the capillaries of the brain, whose endothelial cells form the so-called blood-brain barrier. Understanding the cellular and molecular structure as well as integrated function of this barrier is a prerequisite for successful drug delivery to the brain. Here we briefly review current knowledge about the active transport proteins (ABC and organic anion transporters) which function at the blood-brain barrier. We describe novel approaches to (1). modulate carrier protein function, and (2). circumvent the transporter-based carrier by targeted site-specific drug delivery systems, such as immunoliposome and nanoparticulate systems.Keywords
This publication has 29 references indexed in Scilit:
- Contribution of Organic Anion Transporter 3 (Slc22a8) to the Elimination of p-Aminohippuric Acid and Benzylpenicillin across the Blood-Brain BarrierThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Pluronic® block copolymers as modulators of drug efflux transporter activity in the blood–brain barrierPublished by Elsevier ,2002
- Morphological and cytochemical aspects of capillary permeabilityMicroscopy Research and Technique, 2002
- A new multidrug resistance protein at the blood–brain barrierBiochemical and Biophysical Research Communications, 2002
- By-passing of P-glycoprotein Using ImmunoliposomesJournal of Drug Targeting, 2002
- Uptake of Cationized Albumin Coupled Liposomes by Cultured Porcine Brain Microvessel Endothelial Cells and Intact Brain CapillariesJournal of Drug Targeting, 2002
- Pluronic P85 Block Copolymer Enhances Opioid Peptide AnalgesiaThe Journal of Pharmacology and Experimental Therapeutics, 2002
- P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brainNeuroReport, 2001
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsPublished by Elsevier ,1994
- Distribution of valproate across the interface between blood and cerebrospinal fluidNeuropharmacology, 1978